|
|
|
|
LEADER |
01120naa a2200253 i 4500 |
001 |
acta67019 |
005 |
20221108131933.0 |
008 |
200325s2020 hu o 1|| zxx d |
022 |
|
|
|a 2064-4825
|
024 |
7 |
|
|a 10.14232/syrptbrs.2020.op7
|2 doi
|
040 |
|
|
|a SZTE Egyetemi Kiadványok Repozitórium
|b hun
|
041 |
|
|
|a zxx
|
100 |
1 |
|
|a Barbălată Cristina
|
245 |
1 |
0 |
|a QbD development of a liposomal co-formulation with Doxorubicin and Simvastatin for an enhanced antiproliferative effect on T47D-KBluc cell line
|h [elektronikus dokumentum] /
|c Barbălată Cristina
|
260 |
|
|
|c 2020
|
300 |
|
|
|a 7
|
490 |
0 |
|
|a Symposium of Young Researchers on Pharmaceutical Technology, Biotechnology and Regulatory Science
|v 2
|
695 |
|
|
|a Gyógyszertechnológia - előadáskivonat
|
700 |
0 |
1 |
|a Porfire Alina
|e aut
|
700 |
0 |
1 |
|a Cherfan Anca
|e aut
|
700 |
0 |
1 |
|a Loghin Felicia
|e aut
|
700 |
0 |
1 |
|a Tomuță Ioan
|e aut
|
710 |
|
|
|a Symposium of Young Researchers on Pharmaceutical Technology, Biotechnology and Regulatory Science (2.) (2020) (Szeged)
|
856 |
4 |
0 |
|u http://acta.bibl.u-szeged.hu/67019/1/syrptbrs_2020_012.pdf
|z Dokumentum-elérés
|